Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration

Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration

Abstract Introduction SB11 (Byooviz™) is a ranibizumab biosimilar that acts as a vascular endothelial growth factor (VEGF)-A inhibitor. Stability data for unopened SB11 vials at room temperature are limited and no data are available for SB11 withdrawn into syringes (in-use) for intravitreal administ...

Full description

Bibliographic Details
Main Authors: Peter K. Kaiser, Jihoon Yun, Soyeon Kim, Jihyun Kim, Su Jin Park
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-01-01
Series:Ophthalmology and Therapy
Subjects:
Biosimilar
Byooviz
Eye disease
In-use
Intravitreal injection
Lucentis
Online Access:https://doi.org/10.1007/s40123-022-00645-1

Similar Items

Similar Items